Treating Multiple Myeloma by Targeting the NF-Kappa-B Pathway with Gadd45-Beta/MKK7 Inhibitors

Brenda M Birmann

Diet patterns, aspirin use, obesity and multiple myeloma: a prospective analysis

Multiple myeloma and immunoproliferative diseases

Tracy L Mcgaha

The role of marginal zone macrophages and immuno-metabolism in tumor-driven MDSC development

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Hodgkin lymphoma

Hematology and hematologic malignancies Pathology

Investigator from VU University Amsterdam

Generation of safe and efficient, off-the-shelf, chimeric antigen receptor (CAR)-engineered T cells for broad application

Multiple myeloma and immunoproliferative diseases

Timothy A Springer

Integrin-Targeted siRNA Delivery for Therapeutic Gene Silencing in Blood Cancers

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies

Laura B Freeman

Pooling project of NCI and Cross-Canada studies

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases Leukaemia Hodgkin lymphoma

Hematology and hematologic malignancies

Jonathan Hofmann

Pooled Investigation of Circulating Adiponectin and Multiple Myeloma and Immunoproliferative Diseases in the NCI Cohort Consortium

Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Jing Yang

Targeting adipocyte-secreted chemerin for chemotherapy resistance in myeloma

Multiple myeloma and immunoproliferative diseases

David L Woodland

Immune Evolution in Cancer

Non-Hodgkin lymphoma Multiple myeloma and immunoproliferative diseases

Hematology and hematologic malignancies Pathology

Ping Xie

Molecular mechanisms of B cell malignant transformation

Multiple myeloma and immunoproliferative diseases Melanoma of skin Non-Melanoma skin cancer Leukaemia